Concepedia

Daniel Jericó

DJ

5

Publications

247

Citations

5

H-Index

2018

Active since

Affiliations

Instituto de Salud Carlos III(Current)

Navarre Institute of Health Research

Universidad de Navarra

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

Moderna Therapeutics (United States)

Daniel Jericó is an author at Instituto de Salud Carlos III.

Publications per year

2018–2022

5

Publications

5

Systemic messenger RNA as an etiological treatment for acute intermittent porphyria

Lei Jiang, Pedro Berraondo, Daniel Jericó et al. · Nature Medicine · 2018 · 176 citations · Full text

High Prevalence of Insulin Resistance in Asymptomatic Patients with Acute Intermittent Porphyria and Liver-Targeted Insulin as a Novel Therapeutic Approach

Isabel Solares, Laura Izquierdo‐Sánchez, Montserrat Morales‐Conejo et al. · Biomedicines · 2021 · 22 citations · Full text

mRNA-based therapy in a rabbit model of variegate porphyria offers new insights into the pathogenesis of acute attacks

Daniel Jericó, Karol M. Córdoba, Lei Jiang et al. · Molecular Therapy — Nucleic Acids · 2021 · 19 citations · Full text

Disease pharmacokinetic–pharmacodynamic modelling in acute intermittent porphyria to support the development of <scp>mRNA</scp>‐based therapies

Zinnia P. Parra‐Guillén, Antonio Fontanellas, Lei Jiang et al. · British Journal of Pharmacology · 2020 · 15 citations · Full text

Recombinant porphobilinogen deaminase targeted to the liver corrects enzymopenia in a mouse model of acute intermittent porphyria

Karol M. Córdoba, Irantzu Serrano-Mendioroz, Daniel Jericó et al. · Science Translational Medicine · 2022 · 15 citations · Full text

Rows per page

1–5 of 5